Financhill
Back

Novartis AG 10K Form

Buy
62

NVS
Novartis AG

Last Price:
105.17
Seasonality Move:
2.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $46.66B
Cash Flow: $1.11B
Price / Cash Flow: 21.31
Annual Sales: $19.44
Price / Book: 5.41

Profitability

EPS (TTM): 7.33000
Net Income (TTM): $15.25B
Gross Margin: $34.19B
Return on Equity: 33.31%
Return on Assets: 14.38%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVS is 73.27%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 26.83% of Gross Profit Margin.
  • The Research & Development expenses have been 24.37% of Revenue.
  • The Interest Expense is 5.76% of Operating Income.
  • The Net Earning history of NVS is 31.83% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 0.9
Quick Ratio: 0.61

Price-to-Earnings

Trailing P/E Ratio: 14.82
Forward P/E Ratio: 13.13

NVS Technical Analysis vs Fundamental Analysis

Buy
62
Novartis AG (NVS) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVS] share price is $105.22. The Score for NVS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.